Olio Labs

Sex differences in GLP-1 signaling across species biorxiv.org/content/10.110… #biorxiv_sysbio

Some really cool work we've been doing @OlioLabsInc. New science opens the door to better medicines.

We are building our platforms to solve these problems, and deliver better outcomes with fewer side effects to more people. Get in touch if you want to be a part of our vision. oliolabs.co

Check out a write up of the results here: prnewswire.com/news-releases/… And the PDF here: oliolabs.co/20250318_OlioL…

Check out what we're working on at Olio Labs! 70% of patients taking GLP-1's (like Ozempic) are women, but they experience >2x side effect rates than men. What is driving this difference? We combine human EMR data, mouse & rat behavior, and scRNAseq to figure it out: